How many insider trades does FilingIQ track for EIKN?

FilingIQ tracks 87 Form 4 insider transactions for EIKN (Eikon Therapeutics, Inc.), covering filings from Feb 4, 2026 onwards. 7 of those were filed in the last 90 days.

Are EIKN insiders net buyers or net sellers?

Across the full Form 4 history for EIKN, 9 transactions (10%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does EIKN insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is EIKN in?

Eikon Therapeutics, Inc. (EIKN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $825.69M.

EIKN insider trading

Healthcare

Eikon Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

10% / 0%

Market cap

$825.69M

About Eikon Therapeutics, Inc.

Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs using a platform that permits precise characterization of protein interactions in living cells. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent WRN helicase inhibitor and anti-tumor agent for MSI-high tumors; and EIK1006, a clinical candidate and next-generation androgen receptor antagonist with activity against multiple clinically emergent variants of androgen receptor. The company was incorporated in 2019 and is based in Millbrae, California.

Company website: eikontx.com

EIKN insider activity at a glance

FilingIQ has scored 87 insider transactions for EIKN since Feb 4, 2026. The most recent filing in our index is dated Mar 2, 2026.

Across the full history, 9 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on EIKN insider trades is 61.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live EIKN trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for EIKN?: FilingIQ tracks 87 Form 4 insider transactions for EIKN (Eikon Therapeutics, Inc.), covering filings from Feb 4, 2026 onwards. 7 of those were filed in the last 90 days.
Are EIKN insiders net buyers or net sellers?: Across the full Form 4 history for EIKN, 9 transactions (10%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does EIKN insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is EIKN in?: Eikon Therapeutics, Inc. (EIKN) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $825.69M.

Methodology & sources

Every EIKN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.